The combination of the Biotechnology Division of the German company Sartorius AG and French-based Stedim S.A. has been wrapped up. On Friday, the 29th of June.2007, Sartorius has acquired the share package from the Stedim founders. At the extraordinary general meeting that took place in Paris, Stedim shareholders approved the contribution of the carved-out Biotechnology Division from Sartorius into Stedim and thus the increase in capital this entailed. Therefore, Sartorius is the majority shareholder with a controlling stake in the new company.
In addition, the shareholders also resolved to rename Stedim S.A. to Sartorius Stedim Biotech S.A., and elected the members for the new company’s board. Sartorius CEO and Executive Board Chairman Joachim Kreuzburg was elected Chairman of the Board and Chief Executive Officer (CEO). In addition, the board includes members with an executive function: Liliane de Lassus, Volker Niebel and Reinhard Vogt. Members with a non-executive function on the board are Bernard Lemaître, the founder of Stedim Biosystems S.A.; Arnold Picot, Chairman of the Sartorius AG Supervisory Board; and Henri Riey.
Share:
